Lithuanian biotech startup's new €6.5M seed funding to propel AI-based enzyme design into new frontiers

Biomatter, a Vilnius-based startup in enzyme design, has closed a significant €6.5 million seed funding round led by Inventure and UVC Partners, with support from Practica Capital, Metaplanet, and several industry experts. Biomatter, renowned for its pioneering work with generative AI in enzyme creation, plans to use the funding to enhance its Intelligent Architecture™ platform. This innovative technology enables the design of entirely new enzymes from scratch, overcoming the limitations of traditional methods. With a global client roster including Thermo Fisher Scientific and BASF, the funding will accelerate the development of novel enzyme…